目前,人们认为手术切除仍是原发性肺癌的根治方法。但切除后的总治愈率仅为30%,并有复发的可能。组织学证明,原发性肺癌行根治性切除的患者,其局部及远处器官残瘤率约占40%。另有学者报道,在根治性切除及血源性多发微小转移的病例,其失败率约占50%。因此,为控制肺癌的复发和提高原发肺癌切除患者的存活率,有必要于术后给予有效的辅助治 At present, it is believed that surgical resection is still the cure for primary lung cancer. However, the total cure rate after resection was only 30%, and there was a possibility of recurrence. Histology demonstrated that patients with primary lung cancer underwent radical resection, and the local and distant organ residual tumors accounted for approximately 40%. Another scholar has reported that in the cases of radical resection and multiple micrometastases of blood origin, the failure rate accounts for about 50%. Therefore, in order to control the recurrence of lung cancer and improve the survival rate of patients with primary lung cancer resection, it is necessary to give effective adjuvant treatment after surgery.